Loading…
Progyny, Inc. is projected to rise to $39.90 by 2027, a +30% move from its current price of $30.65. PGNY is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $30.18 | $30.68 | $31.18 | +0.09% |
| Jul 15 | $30.00 | $30.70 | $31.42 | +0.17% |
| Jul 16 | $29.87 | $30.73 | $31.61 | +0.26% |
| Jul 17 | $29.77 | $30.76 | $31.78 | +0.35% |
| Jul 18 | $29.68 | $30.78 | $31.93 | +0.44% |
| Jul 19 | $29.60 | $30.81 | $32.07 | +0.52% |
| Jul 20 | $29.54 | $30.84 | $32.20 | +0.61% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $29.54 | $30.84 | $32.20 | +0.61% |
| Week 2 | $29.19 | $31.03 | $32.98 | +1.22% |
| Week 3 | $28.97 | $31.21 | $33.64 | +1.84% |
| Week 4 | $28.81 | $31.41 | $34.23 | +2.46% |
| Week 5 | $28.69 | $31.60 | $34.80 | +3.09% |
| Week 6 | $28.60 | $31.79 | $35.33 | +3.72% |
| Week 7 | $28.53 | $31.98 | $35.85 | +4.35% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Progyny, Inc. is a healthcare company that provides fertility, family building, and women's health benefits solutions in the United States. Its portfolio includes fertility benefits plan design, personalized concierge-style member support services, and a selective network of fertility specialists, together with Progyny Rx, an integrated pharmacy benefits solution that provides access to medications during treatment and care management services for pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions.
The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Progyny (PGNY) is a healthcare company focused on fertility and women’s health benefits in the United States, with a current price of $30.93 and a market cap of $2.42B. It ranks 1891 in market capitalization. The stock’s near-term outlook shows a flat-to-neutral path in 2026, while the longer horizon projects meaningful upside with a multi-year forecast reaching well above current levels.
A major floor 46.8% below — a decisive break under it would weaken the trend.
The nearest floor, 18.5% below — buyers have tended to step in here.
Price is pressing into resistance (1.4% away) — a breakout level to watch.
A major ceiling 14.1% above — clearing it would confirm fresh momentum.
Key PGNY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PGNY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $30.84 | Sell | $30.59 | Buy |
| MA 10 | $30.01 | Buy | $29.90 | Buy |
| MA 20 | $28.27 | Buy | $28.63 | Buy |
| MA 50 | $25.34 | Buy | $25.91 | Buy |
| MA 100 | $21.75 | Buy | $23.97 | Buy |
| MA 200 | $22.54 | Buy | $22.99 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 76.27 | Sell |
| Stoch RSI (14) | 63.94 | Neutral |
| CCI (20) | 91.41 | Neutral |
| Williams %R (14) | -8.77 | Info |
| MACD (12,26,9) | 0.14 | Buy |
| ROC (12) | 15.10 | Buy |
| Bollinger %B (20,2) | 0.82 | Neutral |
| Stochastic %K (14) | 91.23 | Sell |
| TRIX (15) | 0.83 | Buy |
| Awesome (5,34) | 3.72 | Buy |
| Ultimate (7,14,28) | 81.85 | Sell |
| Momentum (10) | 3.27 | Buy |
| Aroon Osc (25) | 96.00 | Buy |
| Hull MA (9) | 31.23 | Sell |
| ADX (14) | 47.70 | Buy |
| ATR (14) | 0.41 | Info |
The 30-day technical picture is bullish, with RSI14 at 80 indicating strong momentum. The stock trades near a key resistance at $30.93, and its 30-day range spans from $27.47 to $34.82.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $16.30 | $30.65 | $42.03 | 0% | Neutral | |
| $32.68 | $39.90 | $50.93 | +30% | Bullish | |
| $38.40 | $47.76 | $62.62 | +56% | Bullish | |
| $48.09 | $60.74 | $81.33 | +98% | Bullish | |
| $56.01 | $71.70 | $97.74 | +134% | Bullish | |
| $70.57 | $91.44 | $126.61 | +198% | Bullish | |
| $85.65 | $112.24 | $157.63 | +266% | Bullish | |
| $90.11 | $119.33 | $169.74 | +289% | Bullish | |
| $100.69 | $134.66 | $193.85 | +339% | Bullish | |
| $110.20 | $148.78 | $216.56 | +385% | Bullish | |
| $202.61 | $285.31 | $435.20 | +831% | Bullish | |
| $388.81 | $587.19 | $960.11 | +18.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $16.30 | $30.65 | $37.15 | +0.00% |
| August 2026 | $28.09 | $32.88 | $39.32 | +7.28% |
| September 2026 | $28.21 | $33.18 | $39.99 | +0.90% |
| October 2026 | $27.98 | $33.04 | $40.08 | -0.42% |
| November 2026 | $28.49 | $33.77 | $41.19 | +2.20% |
| December 2026 | $28.83 | $34.28 | $42.03 | +1.52% |
Click any year to see its month-by-month PGNY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PGNY is projected to trade between $16.30 and $42.03, averaging $30.65 — a potential gain of 0% from today's $30.65. A consolidation phase looks the most probable path here.
Progyny, Inc.'s 2027 outlook centres on $39.90, within a $32.68 to $50.93 range. That is up +30% on the projected 2026 average. That marks a +30% change versus current levels. Momentum favours further upside here.
By 2028, PGNY could reach as high as $62.62, with a base case around $47.76 and support toward $38.40 — roughly +56% from $30.65. Buyers look set to stay in control over this stretch.
Expect PGNY to range from $48.09 to $81.33 through 2029. The $60.74 average target implies a +98% move from current prices. That is up +27% on the projected 2028 average. Momentum favours further upside here.
The PGNY price prediction for 2030 points to an average of $71.70 (low $56.01, high $97.74) — a potential gain of +134% on today's $30.65. Buyers look set to stay in control over this stretch.
In 2031, PGNY is projected to trade between $70.57 and $126.61, averaging $91.44 — a potential gain of +198% from today's $30.65. That is up +28% on the projected 2030 average. Momentum favours further upside here.
Progyny, Inc.'s 2032 outlook centres on $112.24, within a $85.65 to $157.63 range. That is up +23% on the projected 2031 average. That marks a +266% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, PGNY could reach as high as $169.74, with a base case around $119.33 and support toward $90.11 — roughly +289% from $30.65. Momentum favours further upside here.
Expect PGNY to range from $100.69 to $193.85 through 2034. The $134.66 average target implies a +339% move from current prices. That is up +13% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The PGNY price prediction for 2035 points to an average of $148.78 (low $110.20, high $216.56) — a potential gain of +385% on today's $30.65. Momentum favours further upside here.
In 2040, PGNY is projected to trade between $202.61 and $435.20, averaging $285.31 — a potential gain of +831% from today's $30.65. That is up +92% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Progyny, Inc.'s 2050 outlook centres on $587.19, within a $388.81 to $960.11 range. That is up +106% on the projected 2040 average. That marks a +18.2x change versus current levels. Momentum favours further upside here.
Investing $1,000 in PGNY today (≈ 32.626427 PGNY) could be worth
$19,158.07
+$18,158.07 (+1816%) by 2050 · US Dollar
Based on the average projected PGNY price of $587.19 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PGNYwould be worth at today's price.
$1,000 invested in PGNY on Jul 10, 2025 (≈ 42.354933 PGNY) would be worth
$1,298.18
+$298.18 (+29.8%) today · 1.30× · US Dollar
Based on a PGNY entry price of $23.61 vs. today's $30.65.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $30.22 | $1,014.23 | +1.4% |
| 1 month ago | $25.89 | $1,183.85 | +18.4% |
| 3 months ago | $16.3 | $1,880.37 | +88.0% |
| 6 months ago | $28.42 | $1,078.47 | +7.8% |
| 1 year ago | $23.61 | $1,298.18 | +29.8% |
| All time (5.0y) ago | $56.04 | $546.93 | -45.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PGNY forecast.
Our base-case forecast reaches $61.00 around 2030.
Implied market cap at $61.00: $4.78B
The multi-year forecast shows a steady uptrend after 2026, with 2026: avg $30.93 (neutral) and 2027: avg $40.19 (bullish), 2028: avg $48.20, 2029: avg $60.60, and 2030: avg $71.38 (all bullish) along with corresponding min/max levels. By 2030, the forecast cites a min of $55.75 and a max of $97.33 with ROI 130.8; by 2040, avg is $282.71 with ROI 814; by 2050, avg is $572.65 with ROI 1751.4. These projections imply substantial upside over the long term but are estimates and involve inherent uncertainty and volatility (the volatility metric is 30%).
Tap a question to reveal the answer.
The forecast shows an average price of $71.38 with a min of $55.75 and a max of $97.33, and a projected ROI of 130.8% with bullish sentiment.
Forecasts indicate upside potential on a multi-year horizon, with increasing average prices from $30.93 in 2026 to higher levels through 2030 and beyond, and bullish sentiment in later years, though these are estimates and involve uncertainty.
The forecast shows a 2030 max of $97.33 and a 2031 max of $126.67, so it could surpass $100 by 2031, while the 2030 period does not exceed $100.
The current price is $30.93 and the market cap is $2.42B.
For 2040, the forecast shows an average price of $282.71 with a min of $200.75, a max of $431.28, and a ROI of 814, with bullish sentiment.
Progyny, Inc. Community Discussion
0Share your Progyny, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.